2023 ICD-10-CM Diagnosis Code R76.0

Raised antibody titer

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
  • R76.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2023 edition of ICD-10-CM R76.0 became effective on October 1, 2022.
  • This is the American ICD-10-CM version of R76.0 - other international versions of ICD-10 R76.0 may differ.
Type 1 Excludes
Type 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as R76.0. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • isoimmunization in pregnancy (
    ICD-10-CM Diagnosis Code O36.0

    Maternal care for rhesus isoimmunization

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Applicable To
    • Maternal care for Rh incompatibility (with hydrops fetalis)
    O36.0-
    ICD-10-CM Diagnosis Code O36.1

    Maternal care for other isoimmunization

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Applicable To
    • Maternal care for ABO isoimmunization
    O36.1
    )
  • isoimmunization affecting newborn (
    ICD-10-CM Diagnosis Code P55
    • P55 Hemolytic disease of newborn
      • P55.0 Rh isoimmunization of newborn
      • P55.1 ABO isoimmunization of newborn
      • P55.8 Other hemolytic diseases of newborn
      • P55.9 Hemolytic disease of newborn, unspecified
    P55.-
    )
The following code(s) above R76.0 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to R76.0:
  • R00-R99
    2023 ICD-10-CM Range R00-R99

    Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

    Note
    • This chapter includes symptoms, signs, abnormal results of clinical or other investigative procedures, and ill-defined conditions regarding which no diagnosis classifiable elsewhere is recorded.
    • Signs and symptoms that point rather definitely to a given diagnosis have been assigned to a category in other chapters of the classification. In general, categories in this chapter include the less well-defined conditions and symptoms that, without the necessary study of the case to establish a final diagnosis, point perhaps equally to two or more diseases or to two or more systems of the body. Practically all categories in the chapter could be designated 'not otherwise specified', 'unknown etiology' or 'transient'. The Alphabetical Index should be consulted to determine which symptoms and signs are to be allocated here and which to other chapters. The residual subcategories, numbered .8, are generally provided for other relevant symptoms that cannot be allocated elsewhere in the classification.
    • The conditions and signs or symptoms included in categories R00-R94 consist of:
    • (a) cases for which no more specific diagnosis can be made even after all the facts bearing on the case have been investigated;
    • (b) signs or symptoms existing at the time of initial encounter that proved to be transient and whose causes could not be determined;
    • (c) provisional diagnosis in a patient who failed to return for further investigation or care;
    • (d) cases referred elsewhere for investigation or treatment before the diagnosis was made;
    • (e) cases in which a more precise diagnosis was not available for any other reason;
    • (f) certain symptoms, for which supplementary information is provided, that represent important problems in medical care in their own right.
    Type 2 Excludes
    • abnormal findings on antenatal screening of mother (O28.-)
    • certain conditions originating in the perinatal period (P04-P96)
    • signs and symptoms classified in the body system chapters
    • signs and symptoms of breast (N63, N64.5)
    Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
  • R70-R79
    2023 ICD-10-CM Range R70-R79

    Abnormal findings on examination of blood, without diagnosis

    Type 2 Excludes
    • abnormal findings on antenatal screening of mother (O28.-)
    • abnormalities of lipids (E78.-)
    • abnormalities of platelets and thrombocytes (D69.-)
    • abnormalities of white blood cells classified elsewhere (D70-D72)
    • coagulation hemorrhagic disorders (D65-D68)
    • diagnostic abnormal findings classified elsewhere - see Alphabetical Index
    • hemorrhagic and hematological disorders of newborn (P50-P61)
    Abnormal findings on examination of blood, without diagnosis
Approximate Synonyms
  • Elevated antibody titer
  • Elevated antinuclear antibody (ana) titer
  • Elevated h pylori antibody
  • Elevated rheumatoid factor
  • High antibody titer
  • Raised antinuclear antibody
  • Raised helicobacter pylori antibody
  • Rheumatoid factor positive
ICD-10-CM R76.0 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
  • 814 Reticuloendothelial and immunity disorders with mcc
  • 815 Reticuloendothelial and immunity disorders with cc
  • 816 Reticuloendothelial and immunity disorders without cc/mcc

Convert R76.0 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
Code annotations containing back-references to R76.0:
  • Type 1 Excludes: D68.312
    , D68.312
    , D68.312
    , D68.5
    , D68.61
    , D68.62
    ICD-10-CM Diagnosis Code D68.312

    Antiphospholipid antibody with hemorrhagic disorder

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
    Applicable To
    • Lupus anticoagulant (LAC) with hemorrhagic disorder
    • Systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder
    Type 1 Excludes
    • antiphospholipid antibody, finding without diagnosis (R76.0)
    • antiphospholipid antibody syndrome (D68.61)
    • antiphospholipid antibody with hypercoagulable state (D68.61)
    • lupus anticoagulant (LAC) finding without diagnosis (R76.0)
    • lupus anticoagulant (LAC) with hypercoagulable state (D68.62)
    • systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
    • systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.62)
    ICD-10-CM Diagnosis Code D68.312

    Antiphospholipid antibody with hemorrhagic disorder

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
    Applicable To
    • Lupus anticoagulant (LAC) with hemorrhagic disorder
    • Systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder
    Type 1 Excludes
    • antiphospholipid antibody, finding without diagnosis (R76.0)
    • antiphospholipid antibody syndrome (D68.61)
    • antiphospholipid antibody with hypercoagulable state (D68.61)
    • lupus anticoagulant (LAC) finding without diagnosis (R76.0)
    • lupus anticoagulant (LAC) with hypercoagulable state (D68.62)
    • systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
    • systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.62)
    ICD-10-CM Diagnosis Code D68.312

    Antiphospholipid antibody with hemorrhagic disorder

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
    Applicable To
    • Lupus anticoagulant (LAC) with hemorrhagic disorder
    • Systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder
    Type 1 Excludes
    • antiphospholipid antibody, finding without diagnosis (R76.0)
    • antiphospholipid antibody syndrome (D68.61)
    • antiphospholipid antibody with hypercoagulable state (D68.61)
    • lupus anticoagulant (LAC) finding without diagnosis (R76.0)
    • lupus anticoagulant (LAC) with hypercoagulable state (D68.62)
    • systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
    • systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.62)
    ICD-10-CM Diagnosis Code D68.5

    Primary thrombophilia

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Applicable To
    • Primary hypercoagulable states
    Type 1 Excludes
    • antiphospholipid syndrome (D68.61)
    • lupus anticoagulant (D68.62)
    • secondary activated protein C resistance (D68.69)
    • secondary antiphospholipid antibody syndrome (D68.69)
    • secondary lupus anticoagulant with hypercoagulable state (D68.69)
    • secondary systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.69)
    • systemic lupus erythematosus [SLE] inhibitor finding without diagnosis (R76.0)
    • systemic lupus erythematosus [SLE] inhibitor with hemorrhagic disorder (D68.312)
    • thrombotic thrombocytopenic purpura (M31.19)
    ICD-10-CM Diagnosis Code D68.61

    Antiphospholipid syndrome

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
    Applicable To
    • Anticardiolipin syndrome
    • Antiphospholipid antibody syndrome
    Type 1 Excludes
    • anti-phospholipid antibody, finding without diagnosis (R76.0)
    • anti-phospholipid antibody with hemorrhagic disorder (D68.312)
    • lupus anticoagulant syndrome (D68.62)
    ICD-10-CM Diagnosis Code D68.62

    Lupus anticoagulant syndrome

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
    Applicable To
    • Lupus anticoagulant
    • Presence of systemic lupus erythematosus [SLE] inhibitor
    Type 1 Excludes
    • anticardiolipin syndrome (D68.61)
    • antiphospholipid syndrome (D68.61)
    • lupus anticoagulant (LAC) finding without diagnosis (R76.0)
    • lupus anticoagulant (LAC) with hemorrhagic disorder (D68.312)

Diagnosis Index entries containing back-references to R76.0:
  • Antibody
  • Elevated, elevation
    • antibody titer R76.0
  • Findings, abnormal, inconclusive, without diagnosis - see also Abnormal
    • antibody titer, elevated R76.0
    • anticardiolipin antibody R76.0
    • antiphosphatidylglycerol antibody R76.0
    • antiphosphatidylinositol antibody R76.0
    • antiphosphatidylserine antibody R76.0
    • antiphospholipid antibody R76.0
  • Lupus
    • anticoagulant D68.62
      ICD-10-CM Diagnosis Code D68.62

      Lupus anticoagulant syndrome

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
      Applicable To
      • Lupus anticoagulant
      • Presence of systemic lupus erythematosus [SLE] inhibitor
      Type 1 Excludes
      • anticardiolipin syndrome (D68.61)
      • antiphospholipid syndrome (D68.61)
      • lupus anticoagulant (LAC) finding without diagnosis (R76.0)
      • lupus anticoagulant (LAC) with hemorrhagic disorder (D68.312)
      • finding without diagnosis R76.0
    • erythematosus (discoid) (local) L93.0
      ICD-10-CM Diagnosis Code L93.0

      Discoid lupus erythematosus

        2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
      Applicable To
      • Lupus erythematosus NOS
      • systemic M32.9
        ICD-10-CM Diagnosis Code M32.9

        Systemic lupus erythematosus, unspecified

          2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
        Applicable To
        • SLE NOS
        • Systemic lupus erythematosus NOS
        • Systemic lupus erythematosus without organ involvement
        • inhibitor (presence of) D68.62
          ICD-10-CM Diagnosis Code D68.62

          Lupus anticoagulant syndrome

            2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
          Applicable To
          • Lupus anticoagulant
          • Presence of systemic lupus erythematosus [SLE] inhibitor
          Type 1 Excludes
          • anticardiolipin syndrome (D68.61)
          • antiphospholipid syndrome (D68.61)
          • lupus anticoagulant (LAC) finding without diagnosis (R76.0)
          • lupus anticoagulant (LAC) with hemorrhagic disorder (D68.312)
          • finding without diagnosis R76.0
  • Raised - see also Elevated
    • antibody titer R76.0

ICD-10-CM Codes Adjacent To R76.0
R73.09 Other abnormal glucose
R73.9 Hyperglycemia, unspecified
R74 Abnormal serum enzyme levels
R74.0 Nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
R74.01 Elevation of levels of liver transaminase levels
R74.02 Elevation of levels of lactic acid dehydrogenase [LDH]
R74.8 Abnormal levels of other serum enzymes
R74.9 Abnormal serum enzyme level, unspecified
R75 Inconclusive laboratory evidence of human immunodeficiency virus [HIV]
R76 Other abnormal immunological findings in serum
R76.0 Raised antibody titer
R76.1 Nonspecific reaction to test for tuberculosis
R76.11 Nonspecific reaction to tuberculin skin test without active tuberculosis
R76.12 Nonspecific reaction to cell mediated immunity measurement of gamma interferon antigen response without active tuberculosis
R76.8 Other specified abnormal immunological findings in serum
R76.9 Abnormal immunological finding in serum, unspecified
R77 Other abnormalities of plasma proteins
R77.0 Abnormality of albumin
R77.1 Abnormality of globulin
R77.2 Abnormality of alphafetoprotein
R77.8 Other specified abnormalities of plasma proteins

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.